2012 thomson reuters australia citation & innovation awards

CITATION AWARDEES
Research Field: Geosciences
Professor Kurt Lambeck
Australian National University Research School of Earth Sciences
Canberra
ACT 0200
Professor Kurt Lambeck’s research deals with the motions and deformations of the Earth, on time scales from
hours to millions of years, with the objective of understanding the forces that shape the planet, including
the interactions of the oceans, atmosphere and cryosphere with the solid part of the earth. He is the leading
proponent of developing and integrating geodetic methods with other geoscience disciplines of geophysics,
geology and environmental science and over a career of more than three decades he has played a central role
in most of the significant advances in this field.
His studies have led to improved understanding of the orbital movements of earth satellites, of the dynamics
of the Earth system, and to predictive models of the planet’s behaviour. These contributions have crossed
diverse sub-disciplines of geoscience but they all have the common goal of understanding the dynamics of the
Earth system over a broad range of time and length scales.
Kurt Lambeck is the immediate past president of the Australian Academy of Science and professor emeritus at
the Australian National University. Currently he holds a Blaise Pascal Chair at the Ecole Normale Superieure,
Paris. He is, amongst others, a member of the Royal Society, the French Academy of Science, and the US
National Academy of Science.
*Mr Andrew P. Roberts, Director Research School of Earth Sciences at the Australian National University
will be accepting this award on behalf of Professor Kurt Lambeck.
Research Field: Immunology
Professor Fabienne Mackay
Monash University
Department of Immunology
Alfred Medical Research & Education Precinct (AMREP)
Level 2, Monash University Building
Commercial Road, Melbourne
VIC 3004
Professor Fabienne Mackay obtained her Ph D in 1994 at the Louis Pasteur University in Strasbourg under the
co-supervision of Dr Werner Lesslauer (Hoffmann La Roche, Basel Switzerland) and Prof. Diane Mathis (now
at the Joslin Institute Boston USA). In 1994, Fabienne joined Biogen Idec Inc. in Boston where she dissected
the role of a TNF-like ligand lymphotoxin-alpha/beta in autoimmunity and cancer. This work led to many
patents and the development of two new treatments currently tested in the clinic.
In 2000, Fabienne joined the Garvan Institute in Sydney as a Welcome Trust senior research fellow and was
awarded a NHMRC program grant. Fabienne’s lab at the Garvan discovered the role of a new molecule named
BAFF as a key B cell survival factor essential for the maturation of B-lymphocytes but also playing a role in
autoimmunity, and became the leading group on BAFF research. In March 2006, Fabienne was appointed
to Director of the Autoimmunity Research Unit and adjunct full professor at the Faculty of medicine of the
University of New South Wales. Fabienne is a consultant for several biotech and pharmaceutical groups. In
2007, she joined the national director board of the Australian Society of Medical Research (ASMR). In 2008,
she was the NSW representative for the NHMRC Association for Research Fellows (NARF). Fabienne is an
associate editor for several scientific journals including the Journal of Interferon & Cytokine Research and the
European Journal of Immunology.
In March 2009, Fabienne became the 5th Chair of the Department of Immunology, Monash University, AMREP
campus. In July 2009, belimumab, a therapeutic antibody neutralising BAFF has met the primary endpoints
in a phase III clinical trial with lupus patients and run by GSK and Human Genome Sciences. This clinical
outcome validated a decade of Fabienne’s work on BAFF and autoimmunity.
14